News & Updates

Pre-eclampsia ups venous thromboembolism risk during pregnancy

29 Nov 2023

Women with a history of pre-eclampsia are at increased risk of venous thromboembolism during pregnancy, according to a study.

Pre-eclampsia ups venous thromboembolism risk during pregnancy

29 Nov 2023

COVID-19 infection ups CV risk in people living with HIV

29 Nov 2023 by

People living with HIV (PLWH) who were diagnosed with COVID-19 had a 35-percent higher risk of a major cardiovascular (CV) event in the following year than PLWH without COVID in a Spanish study.

COVID-19 infection ups CV risk in people living with HIV

29 Nov 2023

PIBIK: Switching to B/F/TAF maintains HIV suppression through 48 weeks

28 Nov 2023 by

Viral suppression is maintained through 48 weeks in adults with HIV-1 harbouring drug resistance mutations, who switched to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) fixed-dose combination pill from a boosted protease inhibitor (bPI) therapy, according to recent data from the phase IV open-label PIBIK trial.

PIBIK: Switching to B/F/TAF maintains HIV suppression through 48 weeks

28 Nov 2023

Some signal of benefit found for liberal transfusion strategy for anaemic heart attack patients

28 Nov 2023 by

Adopting a liberal blood transfusion strategy in patients with acute myocardial infarction (AMI) and anaemia does not appear to do much in terms of reducing the risk of AMI recurrence or death compared with a restrictive transfusion strategy, although there appears to be a hint of benefit, as shown in the results of the phase III MINT trial.

Some signal of benefit found for liberal transfusion strategy for anaemic heart attack patients

28 Nov 2023

HRV/EV infections affect the respiratory system, yield low mortality rates

28 Nov 2023

The respiratory system is the main target of human rhinovirus/enterovirus (HRV/EV) infections, which show a clinical course with low mortality rates, reveals a study.

HRV/EV infections affect the respiratory system, yield low mortality rates

28 Nov 2023

Givosiran delivers safe, sustained improvements in acute hepatic porphyria

28 Nov 2023 by

Long-term monthly treatment with givosiran has good tolerability and offers continuous improvements to patients with acute hepatic porphyria (AHP), results of the phase III ENVISION trial have shown.

Givosiran delivers safe, sustained improvements in acute hepatic porphyria

28 Nov 2023

Omega 6 fatty acids do not influence AF development

28 Nov 2023

Biomarkers of omega 6 (n‒6) fatty acids, including linoleic acid (LA) and arachidonic acid (AA), show no significant relationship with incident atrial fibrillation (AF), a study has found.

Omega 6 fatty acids do not influence AF development

28 Nov 2023

Convalescent plasma cuts death in mechanically ventilated patients with COVID-19-induced ARDS

28 Nov 2023 by

In the CONFIDENT trial, convalescent plasma (CCP) conferred a mortality benefit for patients with COVID-19-induced acute respiratory distress syndrome (ARDS) who were on invasive mechanical ventilation (IMV).

Convalescent plasma cuts death in mechanically ventilated patients with COVID-19-induced ARDS

28 Nov 2023

Intracranial atherosclerosis disease linked to cognitive impairment, dementia

28 Nov 2023

Individuals with intracranial atherosclerosis disease (ICAD) have a heightened risk of cognitive impairment and dementia, according to the results of a systematic review and meta-analysis.

Intracranial atherosclerosis disease linked to cognitive impairment, dementia

28 Nov 2023

Biologic dose optimization not needed in UC patients with early nonresponse, high drug clearance

27 Nov 2023

For patients with ulcerative colitis who are receiving vedolizumab, dose optimization may not be required in the presence of early nonresponse to treatment as well as high drug clearance, according to data from the phase IV ENTERPRET study.

Biologic dose optimization not needed in UC patients with early nonresponse, high drug clearance

27 Nov 2023

News & Updates

Filter by Specialty:

Specialty:

Pre-eclampsia ups venous thromboembolism risk during pregnancy

Pre-eclampsia ups venous thromboembolism risk during pregnancy

COVID-19 infection ups CV risk in people living with HIV

COVID-19 infection ups CV risk in people living with HIV

PIBIK: Switching to B/F/TAF maintains HIV suppression through 48 weeks

PIBIK: Switching to B/F/TAF maintains HIV suppression through 48 weeks

Some signal of benefit found for liberal transfusion strategy for anaemic heart attack patients

Some signal of benefit found for liberal transfusion strategy for anaemic heart attack patients

HRV/EV infections affect the respiratory system, yield low mortality rates

HRV/EV infections affect the respiratory system, yield low mortality rates

Givosiran delivers safe, sustained improvements in acute hepatic porphyria

Givosiran delivers safe, sustained improvements in acute hepatic porphyria

Omega 6 fatty acids do not influence AF development

Omega 6 fatty acids do not influence AF development

Convalescent plasma cuts death in mechanically ventilated patients with COVID-19-induced ARDS

Convalescent plasma cuts death in mechanically ventilated patients with COVID-19-induced ARDS

Intracranial atherosclerosis disease linked to cognitive impairment, dementia

Intracranial atherosclerosis disease linked to cognitive impairment, dementia

Biologic dose optimization not needed in UC patients with early nonresponse, high drug clearance

Biologic dose optimization not needed in UC patients with early nonresponse, high drug clearance